3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
96
Phase 1
35
Phase 1/2
21
Phase 3
12
Phase EARLY_PHASE1
6
Phase NA
5
Phase 4
3
Phase 2/3
1
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
3
INDUSTRY
2
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
3
Head & Neck
1
Gynecologic
1
Genitourinary
1
Conditions
Breast Neoplasms
3
Thyroid Neoplasms
1
Patient Acceptance of Health Care
1
Ovarian Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Dexamethasone
49
Metformin
47
Cyclophosphamide
42
Saline Solution
38
Cytarabine
34
Sodium Chloride
31
Bupivacaine
31
Vincristine
27
Propofol
25
Methotrexate
25
Cisplatin
25
Letrozole
24
Fluorouracil
24
Dexmedetomidine
24
Doxorubicin
23
Fentanyl
22
Carboplatin
22
Etoposide
19
Rituximab
18
Morphine
18
Acetaminophen
18
Lidocaine
17
Granulocyte Colony-Stimulating Factor
17
Bevacizumab
17
Prednisone
16
Mercaptopurine
16
Docetaxel
16
Clomiphene
16
Sevoflurane
15
Idarubicin
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 4
×
OTHER
×
palbociclib
×
Clear all
NCT07487129
2026-03-23
Clinical and P
Beni-Suef University
Phase 4
Completed
206 enrolled
NCT03355157
2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4
Completed
130 enrolled
NCT05949424
2023-11-29
OPTI-DOSE
University Medical Center Groningen
Phase 4
Unknown
30 enrolled